
USA - NASDAQ:APOP -
The current stock price of APOP is 13.17 null. In the past month the price decreased by -28.66%. In the past year, price increased by 81.91%.
Cellect Biotechnology Ltd. offers biomedical services. It provides stem cell transplantation, disease management, regenerative medicine, clinical research and other services. Cellect Biotechnology Ltd. is based in TEL AVIV, Israel.
Cellect Biotechnology Ltd ADR
23 HATA`AS STREET
KFAR SABA L3 44425
CEO: Shai Yarkoni
Phone: 972-9974-1444
Cellect Biotechnology Ltd. offers biomedical services. It provides stem cell transplantation, disease management, regenerative medicine, clinical research and other services. Cellect Biotechnology Ltd. is based in TEL AVIV, Israel.
The current stock price of APOP is 13.17 null. The price increased by 0.38% in the last trading session.
APOP does not pay a dividend.
APOP has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Cellect Biotechnology Ltd ADR (APOP) has a market capitalization of 12.87M null. This makes APOP a Nano Cap stock.
You can find the ownership structure of Cellect Biotechnology Ltd ADR (APOP) on the Ownership tab.
ChartMill assigns a technical rating of 2 / 10 to APOP. When comparing the yearly performance of all stocks, APOP is one of the better performing stocks in the market, outperforming 72.18% of all stocks.
ChartMill assigns a fundamental rating of 1 / 10 to APOP. APOP may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months APOP reported a non-GAAP Earnings per Share(EPS) of -6. The EPS increased by 34.78% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -155.68% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |